| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.63 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.43 | 0.03 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |